PARIS, Oct 22 (Reuters) - Laboratory testing and diagnostics company Eurofins set new financial targets for 2022 as it expands its offering for coronavirus testing, while posting third-quarter results on Thursday.

The company said it would expand such testing to include influenza and respiratory viruses, hoping to achieve revenues of 5.7 billion euros ($6.8 billion) by 2022.

"The group is introducing 2022 objectives, as 2022 should hopefully be the first year where the pandemic is brought under control," Eurofins said in a statement. ($1=0.8442 euros) (Reporting by Sudip Kar-Gupta; Editing by Clarence Fernandez)